Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable TherapiesJAMA Neurol 77:184-191, Luna, G.,et al, 2020
Antibody-Mediated EncephalitisNEJM 378:840-851, Dalmau, J.,et al, 2018